Comments
Loading...
Mirum Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:MIRM | Benzinga
Mirum Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$-0.260
Quarterly Revenue Estimate
$96.09M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$336.89M
Analyze the earnings history of Mirum Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Mirum Pharmaceuticals (MIRM) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-26 | $-0.49 | $-0.25 | -96.0 % |
| Q3 | 2024-11-12 | $-0.30 | $-0.45 | 33.3 % |
| Q2 | 2024-08-07 | $-0.52 | $-0.47 | -10.6 % |
| Q1 | 2024-05-08 | $-0.54 | $-0.48 | -12.5 % |
Mirum Pharmaceuticals (MIRM) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-26 | $99.41M | $96.64M | 2.87 % |
| Q3 | 2024-11-12 | $90.38M | $82.01M | 10.2 % |
| Q2 | 2024-08-07 | $77.88M | $75.25M | 3.49 % |
| Q1 | 2024-05-08 | $69.22M | $70.17M | -1.35 % |
FAQ
When is Mirum Pharmaceuticals (NASDAQ:MIRM) reporting earnings?
Mirum Pharmaceuticals (MIRM) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on February 26, 2025 for Q4.
What were the latest earnings per share (EPS) for Mirum Pharmaceuticals (NASDAQ:MIRM)?
The Actual EPS was $-0.49, which missed the estimate of $-0.25.
What were Mirum Pharmaceuticals’s (NASDAQ:MIRM) revenues?
The Actual Revenue was $99.4M, which beat the estimate of $96.6M.
Browse earnings estimates, EPS, and revenue on all stocks.